Cargando…

Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis

BACKGROUND: Infantile cholestasis (IC) is the most common hepatobiliary disease in infants, resulting in elevated direct bilirubin levels. Indeed, hepatointestinal circulation impacts bile acid and bilirubin metabolism. This study evaluates changes in the gut microbiota composition in children with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Meng, Cui, Jinghua, Ning, Huijuan, Wang, Meijuan, Liu, Wenwen, Yao, Kunyu, Yuan, Jing, Zhong, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656868/
https://www.ncbi.nlm.nih.gov/pubmed/37980506
http://dx.doi.org/10.1186/s12866-023-03115-1
_version_ 1785148088545968128
author Jin, Meng
Cui, Jinghua
Ning, Huijuan
Wang, Meijuan
Liu, Wenwen
Yao, Kunyu
Yuan, Jing
Zhong, Xuemei
author_facet Jin, Meng
Cui, Jinghua
Ning, Huijuan
Wang, Meijuan
Liu, Wenwen
Yao, Kunyu
Yuan, Jing
Zhong, Xuemei
author_sort Jin, Meng
collection PubMed
description BACKGROUND: Infantile cholestasis (IC) is the most common hepatobiliary disease in infants, resulting in elevated direct bilirubin levels. Indeed, hepatointestinal circulation impacts bile acid and bilirubin metabolism. This study evaluates changes in the gut microbiota composition in children with IC and identifies abnormal metabolite profiles associated with microbial alterations. RESULTS: The gut microbiota in the IC group exhibits the higher abundance of Veillonella, Streptococcus and Clostridium spp. (P < 0.05), compared to healthy infants (CON) group. Moreover, the abundance of Ruminococcus, Vibrio butyricum, Eubacterium coprostanogenes group, Intestinibacter, and Faecalibacterium were lower (P < 0.05). In terms of microbiota-derived metabolites, the levels of fatty acids (palmitoleic, α-linolenic, arachidonic, and linoleic) (P < 0.05) increased and the levels of amino acids decreased in IC group. Furthermore, the abundances of Ruminococcus, Eubacterium coprostanoligenes group, Intestinibacter and Butyrivibrio are positively correlated with proline, asparagine and aspartic acid, but negatively correlated with the α-linolenic acid, linoleic acid, palmitoleic acid and arachidonic acid. For analysis of the relationship between the microbiota and clinical index, it was found that the abundance of Veillonella and Streptococcus was positively correlated with serum bile acid content (P < 0.05), while APTT, PT and INR were negatively correlated with Faecalibalum and Ruminococcus (P < 0.05). CONCLUSION: Microbiota dysbiosis happened in IC children, which also can lead to the abnormal metabolism, thus obstructing the absorption of enteral nutrition and aggravating liver cell damage. Veillonella, Ruminococcus and Butyrivibrio may be important microbiome related with IC and need further research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-023-03115-1.
format Online
Article
Text
id pubmed-10656868
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106568682023-11-18 Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis Jin, Meng Cui, Jinghua Ning, Huijuan Wang, Meijuan Liu, Wenwen Yao, Kunyu Yuan, Jing Zhong, Xuemei BMC Microbiol Research BACKGROUND: Infantile cholestasis (IC) is the most common hepatobiliary disease in infants, resulting in elevated direct bilirubin levels. Indeed, hepatointestinal circulation impacts bile acid and bilirubin metabolism. This study evaluates changes in the gut microbiota composition in children with IC and identifies abnormal metabolite profiles associated with microbial alterations. RESULTS: The gut microbiota in the IC group exhibits the higher abundance of Veillonella, Streptococcus and Clostridium spp. (P < 0.05), compared to healthy infants (CON) group. Moreover, the abundance of Ruminococcus, Vibrio butyricum, Eubacterium coprostanogenes group, Intestinibacter, and Faecalibacterium were lower (P < 0.05). In terms of microbiota-derived metabolites, the levels of fatty acids (palmitoleic, α-linolenic, arachidonic, and linoleic) (P < 0.05) increased and the levels of amino acids decreased in IC group. Furthermore, the abundances of Ruminococcus, Eubacterium coprostanoligenes group, Intestinibacter and Butyrivibrio are positively correlated with proline, asparagine and aspartic acid, but negatively correlated with the α-linolenic acid, linoleic acid, palmitoleic acid and arachidonic acid. For analysis of the relationship between the microbiota and clinical index, it was found that the abundance of Veillonella and Streptococcus was positively correlated with serum bile acid content (P < 0.05), while APTT, PT and INR were negatively correlated with Faecalibalum and Ruminococcus (P < 0.05). CONCLUSION: Microbiota dysbiosis happened in IC children, which also can lead to the abnormal metabolism, thus obstructing the absorption of enteral nutrition and aggravating liver cell damage. Veillonella, Ruminococcus and Butyrivibrio may be important microbiome related with IC and need further research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-023-03115-1. BioMed Central 2023-11-18 /pmc/articles/PMC10656868/ /pubmed/37980506 http://dx.doi.org/10.1186/s12866-023-03115-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jin, Meng
Cui, Jinghua
Ning, Huijuan
Wang, Meijuan
Liu, Wenwen
Yao, Kunyu
Yuan, Jing
Zhong, Xuemei
Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
title Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
title_full Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
title_fullStr Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
title_full_unstemmed Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
title_short Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
title_sort alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656868/
https://www.ncbi.nlm.nih.gov/pubmed/37980506
http://dx.doi.org/10.1186/s12866-023-03115-1
work_keys_str_mv AT jinmeng alterationsingutmicrobiotaandmetaboliteprofilesinpatientswithinfantilecholestasis
AT cuijinghua alterationsingutmicrobiotaandmetaboliteprofilesinpatientswithinfantilecholestasis
AT ninghuijuan alterationsingutmicrobiotaandmetaboliteprofilesinpatientswithinfantilecholestasis
AT wangmeijuan alterationsingutmicrobiotaandmetaboliteprofilesinpatientswithinfantilecholestasis
AT liuwenwen alterationsingutmicrobiotaandmetaboliteprofilesinpatientswithinfantilecholestasis
AT yaokunyu alterationsingutmicrobiotaandmetaboliteprofilesinpatientswithinfantilecholestasis
AT yuanjing alterationsingutmicrobiotaandmetaboliteprofilesinpatientswithinfantilecholestasis
AT zhongxuemei alterationsingutmicrobiotaandmetaboliteprofilesinpatientswithinfantilecholestasis